THIS IS A SOURCES SOUGHT NOTICE ONLY. THIS IS NOT A REQUEST FOR PROPOSAL. The Department of Veterans Affairs, VHA, Network Contracting Office (NCO) 19 Rocky Mountain Acquisition Center is seeking potential sources that are capable of providing, chemistry and immunochemistry, including all analyzers, peripheral equipment, reagents, standards, controls, supplies, consumable/disposable items, parts, accessories, maintenance, repair, training and any other item necessary for the generation of a patient Cost per Reportable Result (CPRR). This requirement is for the following VISN 19 facilities: Billings VA Healthcare Center, 1766 Majestic Lane, Billings, MT. 59102. Fort Harrison MT VA Health Care Center 3687 Veterans Drive, P. O. Box 1500 Fort Harrison, MT 59636, Cheyenne VAMC 2360 East Pershing Blvd., Cheyenne WY 82001, Loveland VA Community Clinic 5200 Hahns Peak Drive, Loveland, CO 80538 Sheridan VAHCS, 1898 Fort Rd, Sheridan WY, Grand Junction VAMC, 2121 North Avenue, Grand Junction, CO 81501. NCO 19 is performing market research to determine if there is a sufficient number of qualified (1) Service Disabled Veteran Owned Small Business (SDVOSB); (2) Veteran Owned Small Business (VOSB); (3) Small or emerging small business firms; or (4) Large businesses who can fulfill the requirement. This Sources Sought notice is issued for the purpose of market research in accordance with Federal Acquisition Regulation (FAR) Part 10. All SDVOSB, VOSB, small and large businesses capable of fulfilling the requirement are invited to respond. NAICS code to be used for this acquisition is 334516. All interested firms who can meet the requirements stated in Summary of Requirements below and provide all (or most) of the tests listed in List of Tests, should respond, in writing, with the following information: Interest and Capabilities Address and DUNS Business category (SDVOSB, VOSB, Small Business, or Large Business) State if interested firm has a NAC or GSA contract by replying with their applicable contract number Any information submitted by respondents to this sources sought synopsis is voluntary. This sources sought notice is not to be construed as a commitment by the Government, nor will the Government reimburse any costs associated with the submission of information in response to this notice. Respondents will not individually be notified of the results of any Government assessments. Responses and questions may be submitted electronically to: [email protected] and [email protected] in a Microsoft word compatible format no later than Monday, November 16th, 2020, at 12:00pm Mountain Time. PHONE CALLS NOT ACCEPTED. SUMMARY OF REQUIREMENTS: Cost Per Reportable Result (CPRR): The per reportable result price shall include costs covering (a) equipment use, (b) all reagents, standards, controls, supplies, consumable/disposable items, printers, parts, accessories and any other item required for the proper operation of the contractor s equipment and necessary for the generation of a patient reportable result. This does not include those items approved for exclusion by the government such as printer paper, labels etc. This per patient reportable result price shall also encompass all costs associated with dilution, repeat and confirmatory testing required to produce a single patient reportable result. It will also include the material to perform as well as all other costs associated with quality control (provide control material or credit to purchase controls from other vendor), calibration and correlation study testing that is prescribed by Clinical and Laboratory Standards Institute (CLSI) (c) All necessary maintenance to keep the equipment in good operating condition (This element includes both preventive maintenance and emergency repairs and (d) training for Government personnel. Contractors are required to provide delivery, installation and removal of equipment at no additional charge. Offered models of clinical laboratory chemistry and immunochemistry analyzers shall be capable of producing accurate and reproducible assays on biological and other specimens by established in vitro diagnostic methods (see Proposed Rule by CMS 2/4/19 CLIA Proficiency Testing Regulations Related to Analytes and Acceptable Performance). Instrument models shall provide accurate test assay result for sample specimens up to the manufacturer's defined maximum test per hour without excessive malfunctions, breakdowns, or service calls. Analyzers should be capable of producing clinical chemistry and immunochemistry assays. LIST OF TESTS (The below list is not exclusive. Tests needed are not limited to the list below).   TESTS 1 Acetaminophen 2 Albumin 3 Albumin/Creatinine Ratio 4 Alkaline Phosphatase 5 ALT 6 Alpha-Feto Protein (AFP) 7 Ammonia 8 Amylase 9 AST 10 Beta HCG 11 Beta Hydroxybutyrate 12 Bilirubin, Direct 13 Bilirubin, Total 14 NT-PBNP 15 BUN 16 C-Reactive Protein 17 C3 18 C4 19 Calcium 20 Calcium, Ionized 21 Carbamazepine 22 Carcinoembryonic Ag 23 Chloride 24 Cholesterol, HDL 25 Cholesterol, Total 26 CK see CPK TOT 27 CK-MB 28 CO2 29 Cortisol 30 CPK, total 31 Creatinine 32 Creatinine Urine 33 hs CRP 34 CSF Protein 35 Cyclosporin 36 Digoxin 37 Ethanol, Serum 38 Ferritin 39 Free T3 40 Folate 41 Follicle Stimulating Hormone~ 42 Gentamicin 43 GGT 44 Glucose 45 Haptoglobin 46 Hemoglobin A1C 47 Homocysteine 48 HS-Troponin 49 IgA 50 IgG 51 IgE 52 IgM 53 Iron Saturation 54 Iron, total 55 Kappa Light Chains, Total 56 Kappa Light Chains, Free 57 Lactic acid 58 Lambda Light Chains, Total 59 Lambda Light Chains, Free 60 LDH 61 LDL Cholesterol, Direct 62 Lipase 63 Lithium 64 Luteinizing Hormone 65 Magnesium 66 Microalbumin 67 Parathyroid Hormone Intact 68 Phenobarbital 69 Phenytoin 70 Phosphorous 71 Potassium, plasma 72 Potassium, serum 73 Prealbumin 74 Procalcitonin 75 Prolactin 76 Protein, total 77 PSA 78 PSA, Free 79 Rheumatoid Factor 80 Salicylates 81 Sodium 82 T3Uptake 83 Testosterone 84 THC 85 Theophylline 86 Thyroxine, Total (T4) 87 Thyroxine, FREE 88 TIBC 89 Transferrin 90 Triglycerides 91 Triiodothyronine (T3) 92 Troponin-I (total of RxL and Stratus) 93 TSH 94 UCFP 95 Urea Nitrogen SEE bun 96 Uric acid 97 Urine Protein Total 98 Valproic acid 99 Vancomycin 100 Vitamin B12 101 VLDL 102 Vitamin D 25 Hydroxy   TOX SCREENS 103 6-acetylmorphine (6-AM) 104 ALCOHOL SCREEN URINE 105 AMPHETAMINES 106 BARBITURATES 107 BENZODIAZEPINES 108 BUPRENORPHINE 109 CANNABINOIDS 110 COCAINE 111 ETHANOL, URINE 112 Fentanyl 113 Methamphetamine 114 METHADONE 115 PHENCYCLIDINE (PCP) 116 PROPOXYPHENE 117 OPIATE SCREEN, COMPREHENSIVE 118 OXYCODONE/OXYMORPHONE URINE SCREEN 300 119 OXYCODONE/OXYMORPHONE URINE SCREEN 100 120 Tramadol 121 Tricyclic Antidepressants 122 URINE, PH (Not Tested)   HEPATITIS/HIV SCREENING 123 Hepatitis A Ab, Total 124 Hepatitis A IgM Ab 125 Hepatitis B Core Ab 126 Hepatitis B Core IgM Ab 127 Hepatitis B e AB 128 Hepatitis B Surface Ab 129 Hepatitis B Surface Ag 130 Hepatitis C Ab 131 Hepatitis C Genotype PCR (Not Tested) 132 HIV Ab (1&2) - 4th generation     (END OF DOCUMENT)

Bid Protests Not Available